首页 > 最新文献

Digestive Surgery最新文献

英文 中文
HBPD Table of Contents HBPD目录
IF 2.7 3区 医学 Q1 Medicine Pub Date : 2022-03-01 DOI: 10.1159/000523745
{"title":"HBPD Table of Contents","authors":"","doi":"10.1159/000523745","DOIUrl":"https://doi.org/10.1159/000523745","url":null,"abstract":"","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45883212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Front & Back Matter 正面和背面事项
IF 2.7 3区 医学 Q1 Medicine Pub Date : 2022-03-01 DOI: 10.1159/000524083
D. O’Toole
{"title":"Front & Back Matter","authors":"D. O’Toole","doi":"10.1159/000524083","DOIUrl":"https://doi.org/10.1159/000524083","url":null,"abstract":"","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42995687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EDS Society News EDS社会新闻
IF 2.7 3区 医学 Q1 Medicine Pub Date : 2022-03-01 DOI: 10.1159/000523744
{"title":"EDS Society News","authors":"","doi":"10.1159/000523744","DOIUrl":"https://doi.org/10.1159/000523744","url":null,"abstract":"","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46785425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and Validation of Hub Genes Predicting Prognosis of Hepatocellular Carcinoma. 预测肝细胞癌预后的枢纽基因的鉴定和验证。
IF 2.7 3区 医学 Q1 Medicine Pub Date : 2022-01-01 Epub Date: 2021-11-17 DOI: 10.1159/000520893
Ziyan Chen, Haitao Yu, Lijun Wu, Sina Zhang, Zhihui Lin, Tuo Deng, Bangjie He, Zhengping Yu, Gang Chen, Fang Wu

Introduction: The aim of this study is selecting the hub genes associated with hepatocellular carcinoma (HCC) to construct a Cox regression model for predicting prognosis in HCC patients.

Methods: Using HCC patient data from the ICGC and TCGA databases, screened for 40 core genes highly correlated with histological grade of HCC. Univariate and multivariate Cox regression analyses were performed on the genes highly associated with HCC prognosis, and the model was established. The expression of those genes was measured by immunohistochemistry in 110 HCC patients who underwent the surgery in the First Affiliated Hospital of Wenzhou Medical University. The survival of HCC patients was analyzed by the Kaplan-Meier method.

Results: Eight genes (CDC45, CENPA, MCM10, MELK, CDC20, ASF1B, FANCD2, and NCAPH) were correlated with prognosis, and the same result was observed in 110 HCC patients. Using the regression model, the HCC patients in the training set were classified as high- and low-risk groups. The overall survival of patients in the high-risk group was shorter than that in the low-risk group, and the same results were obtained in the verification set.

Conclusion: This study found that the risk model according to these 8 genes can be used as a predictor of prognosis in HCC. These genes may become alternative biomarkers and therapeutic targets and provide new therapeutic strategies for HCC.

本研究的目的是选择与肝细胞癌(HCC)相关的枢纽基因,构建预测HCC患者预后的Cox回归模型。方法:利用ICGC和TCGA数据库中的HCC患者数据,筛选与HCC组织学分级高度相关的40个核心基因。对HCC预后高度相关基因进行单因素和多因素Cox回归分析,建立模型。在温州医科大学第一附属医院行肝细胞癌手术的110例HCC患者中,用免疫组织化学方法检测了这些基因的表达。采用Kaplan-Meier法分析HCC患者的生存期。结果:8个基因(CDC45、CENPA、MCM10、MELK、CDC20、ASF1B、FANCD2、NCAPH)与预后相关,在110例HCC患者中观察到相同的结果。利用回归模型将训练集中的HCC患者分为高危组和低危组。高危组患者总生存期短于低危组,验证集中结果相同。结论:本研究发现基于这8个基因的风险模型可作为HCC预后的预测因子。这些基因可能成为替代的生物标志物和治疗靶点,并为HCC提供新的治疗策略。
{"title":"Identification and Validation of Hub Genes Predicting Prognosis of Hepatocellular Carcinoma.","authors":"Ziyan Chen,&nbsp;Haitao Yu,&nbsp;Lijun Wu,&nbsp;Sina Zhang,&nbsp;Zhihui Lin,&nbsp;Tuo Deng,&nbsp;Bangjie He,&nbsp;Zhengping Yu,&nbsp;Gang Chen,&nbsp;Fang Wu","doi":"10.1159/000520893","DOIUrl":"https://doi.org/10.1159/000520893","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study is selecting the hub genes associated with hepatocellular carcinoma (HCC) to construct a Cox regression model for predicting prognosis in HCC patients.</p><p><strong>Methods: </strong>Using HCC patient data from the ICGC and TCGA databases, screened for 40 core genes highly correlated with histological grade of HCC. Univariate and multivariate Cox regression analyses were performed on the genes highly associated with HCC prognosis, and the model was established. The expression of those genes was measured by immunohistochemistry in 110 HCC patients who underwent the surgery in the First Affiliated Hospital of Wenzhou Medical University. The survival of HCC patients was analyzed by the Kaplan-Meier method.</p><p><strong>Results: </strong>Eight genes (CDC45, CENPA, MCM10, MELK, CDC20, ASF1B, FANCD2, and NCAPH) were correlated with prognosis, and the same result was observed in 110 HCC patients. Using the regression model, the HCC patients in the training set were classified as high- and low-risk groups. The overall survival of patients in the high-risk group was shorter than that in the low-risk group, and the same results were obtained in the verification set.</p><p><strong>Conclusion: </strong>This study found that the risk model according to these 8 genes can be used as a predictor of prognosis in HCC. These genes may become alternative biomarkers and therapeutic targets and provide new therapeutic strategies for HCC.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39632486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
HBPD Table of Contents HBPD目录
IF 2.7 3区 医学 Q1 Medicine Pub Date : 2022-01-01 DOI: 10.1159/000520691
{"title":"HBPD Table of Contents","authors":"","doi":"10.1159/000520691","DOIUrl":"https://doi.org/10.1159/000520691","url":null,"abstract":"","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44842940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma. 肝外胆管癌炎症评分对预后的影响。
IF 2.7 3区 医学 Q1 Medicine Pub Date : 2022-01-01 Epub Date: 2022-01-20 DOI: 10.1159/000521969
Riki Asakura, Hiroaki Yanagimoto, Tetsuo Ajiki, Daisuke Tsugawa, Takuya Mizumoto, Shinichi So, Takeshi Urade, Yoshihide Nanno, Kenji Fukushima, Hidetoshi Gon, Shohei Komatsu, Kaori Kuramitsu, Tadahiro Goto, Sadaki Asari, Masahiro Kido, Hirochika Toyama, Takumi Fukumoto

Introduction: Although the relationship between systemic inflammatory responses and prognosis has been known in various cancers, it remains unclear which scores are most valuable for determining the prognosis of extrahepatic cholangiocarcinoma. We aimed to verify the usefulness of various inflammation-based scores as prognostic factors in patients with resected extrahepatic cholangiocarcinoma.

Methods: We analyzed consecutive patients undergoing surgical resection for extrahepatic cholangiocarcinoma at our institution between January 2000 and December 2019. The usefulness of the following inflammation-based scores as prognostic factor was investigated: glasgow prognostic score (GPS), modified GPS, neutrophil-to-lymphocyte ratio, platelet to lymphocyte ratio, lymphocyte-to-monocyte ratio, prognostic nutrition index, C-reactive protein to albumin ratio (CAR), controlling nutritional status (CONUT), and prognostic index.

Results: A total of 169 patients were enrolled in this study. Of the nine scores, CAR and CONUT indicated prognostic value. Furthermore, multivariate analysis for overall survival revealed that high CAR (>0.23) was an independent prognostic factor (hazard ratio: 1.816, 95% confidence interval: 1.135-2.906, p = 0.0129), along with lymph node metastasis and curability. There was no difference in tumor staging and short-term outcomes between the low CAR (≤0.23) and high CAR groups.

Conclusions: CAR was the most valuable prognostic score in patients with resected extrahepatic cholangiocarcinoma.

虽然在各种癌症中,系统性炎症反应与预后之间的关系是已知的,但目前尚不清楚哪种评分对确定肝外胆管癌的预后最有价值。我们的目的是验证各种炎症评分作为肝外胆管癌切除术患者预后因素的有效性。方法:我们分析了2000年1月至2019年12月在我院连续接受肝外胆管癌手术切除的患者。研究了以下炎症评分作为预后因素的有效性:格拉斯哥预后评分(GPS)、改良GPS、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、淋巴细胞与单核细胞比值、预后营养指数、c反应蛋白与白蛋白比值(CAR)、控制营养状态(CONUT)和预后指数。结果:本研究共纳入169例患者。在9个评分中,CAR和CONUT显示了预后价值。此外,对总生存率的多因素分析显示,高CAR(>0.23)是一个独立的预后因素(风险比:1.816,95%可信区间:1.135-2.906,p = 0.0129),以及淋巴结转移和治愈率。低CAR组(≤0.23)和高CAR组在肿瘤分期和短期预后方面无差异。结论:CAR是肝外胆管癌切除患者最有价值的预后评分。
{"title":"Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma.","authors":"Riki Asakura,&nbsp;Hiroaki Yanagimoto,&nbsp;Tetsuo Ajiki,&nbsp;Daisuke Tsugawa,&nbsp;Takuya Mizumoto,&nbsp;Shinichi So,&nbsp;Takeshi Urade,&nbsp;Yoshihide Nanno,&nbsp;Kenji Fukushima,&nbsp;Hidetoshi Gon,&nbsp;Shohei Komatsu,&nbsp;Kaori Kuramitsu,&nbsp;Tadahiro Goto,&nbsp;Sadaki Asari,&nbsp;Masahiro Kido,&nbsp;Hirochika Toyama,&nbsp;Takumi Fukumoto","doi":"10.1159/000521969","DOIUrl":"https://doi.org/10.1159/000521969","url":null,"abstract":"<p><strong>Introduction: </strong>Although the relationship between systemic inflammatory responses and prognosis has been known in various cancers, it remains unclear which scores are most valuable for determining the prognosis of extrahepatic cholangiocarcinoma. We aimed to verify the usefulness of various inflammation-based scores as prognostic factors in patients with resected extrahepatic cholangiocarcinoma.</p><p><strong>Methods: </strong>We analyzed consecutive patients undergoing surgical resection for extrahepatic cholangiocarcinoma at our institution between January 2000 and December 2019. The usefulness of the following inflammation-based scores as prognostic factor was investigated: glasgow prognostic score (GPS), modified GPS, neutrophil-to-lymphocyte ratio, platelet to lymphocyte ratio, lymphocyte-to-monocyte ratio, prognostic nutrition index, C-reactive protein to albumin ratio (CAR), controlling nutritional status (CONUT), and prognostic index.</p><p><strong>Results: </strong>A total of 169 patients were enrolled in this study. Of the nine scores, CAR and CONUT indicated prognostic value. Furthermore, multivariate analysis for overall survival revealed that high CAR (>0.23) was an independent prognostic factor (hazard ratio: 1.816, 95% confidence interval: 1.135-2.906, p = 0.0129), along with lymph node metastasis and curability. There was no difference in tumor staging and short-term outcomes between the low CAR (≤0.23) and high CAR groups.</p><p><strong>Conclusions: </strong>CAR was the most valuable prognostic score in patients with resected extrahepatic cholangiocarcinoma.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39927791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Robotic Spleen-Preserving Distal Pancreatectomy with Preservation of Splenic Vessels Using the Gastrohepatic Ligament Approach: The Superior Window Approach in the Kimura Technique. 胃肝韧带入路机械保脾远端胰腺切除术:Kimura技术的上窗入路。
IF 2.7 3区 医学 Q1 Medicine Pub Date : 2022-01-01 DOI: 10.1159/000527249
Kosei Takagi, Ryuichi Yoshida, Yuzo Umeda, Tomokazu Fuji, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

Minimally invasive spleen-preserving distal pancreatectomy (SPDP) is technically challenging, and only a few reports have described surgical approaches for minimally invasive SPDP. This report demonstrates our novel gastrohepatic ligament approach in robotic SPDP with preservation of the splenic vessels (the superior window approach in the Kimura technique). Our gastrohepatic ligament approach for robotic SPDP included four steps. First, the gastrohepatic ligament was divided extensively, and the pancreas was confirmed (step 1). In this step, we did not lift the stomach, nor did we divide the gastrocolic ligament. Next, the superior and inferior borders of the pancreas were dissected, and the tunneling of the pancreas on the superior mesenteric vein was performed (step 2). Following the division of the pancreas (step 3), the pancreatic body and tail were dissected from the medial to the lateral side with preservation of the splenic vessels (step 4). Using this approach, the pancreas can be directly accessed via the gastrohepatic ligament route and dissected without division of the gastrocolic ligament or retraction of the stomach. The present approach for robotic SPDP preserves splenic vessels, facilitating easy access to the pancreas with minimal dissection, and may be optional in selected patients, including those with low body mass index.

微创保脾远端胰腺切除术(SPDP)在技术上具有挑战性,只有少数报道描述了微创SPDP的手术方法。本报告展示了我们在机器人SPDP中采用的新型胃肝韧带入路,该入路保留了脾血管(Kimura技术中的上窗入路)。我们的胃肝韧带入路包括四个步骤。首先,广泛切开胃肝韧带,确认胰腺(步骤1)。这一步我们没有提胃,也没有切开胃结肠韧带。接下来,解剖胰腺上、下边界,并在肠系膜上静脉上凿胰腺隧道(步骤2)。在胰腺分割(步骤3)之后,从内侧到外侧解剖胰腺体和胰腺尾,并保留脾血管(步骤4)。胰腺可经胃肝韧带直接进入,无需分离胃结肠韧带或胃收缩即可切开。目前的机器人SPDP方法保留了脾血管,便于在最小剥离的情况下方便地进入胰腺,并且可能在特定的患者中是可选的,包括那些低体重指数的患者。
{"title":"Robotic Spleen-Preserving Distal Pancreatectomy with Preservation of Splenic Vessels Using the Gastrohepatic Ligament Approach: The Superior Window Approach in the Kimura Technique.","authors":"Kosei Takagi,&nbsp;Ryuichi Yoshida,&nbsp;Yuzo Umeda,&nbsp;Tomokazu Fuji,&nbsp;Kazuya Yasui,&nbsp;Takahito Yagi,&nbsp;Toshiyoshi Fujiwara","doi":"10.1159/000527249","DOIUrl":"https://doi.org/10.1159/000527249","url":null,"abstract":"<p><p>Minimally invasive spleen-preserving distal pancreatectomy (SPDP) is technically challenging, and only a few reports have described surgical approaches for minimally invasive SPDP. This report demonstrates our novel gastrohepatic ligament approach in robotic SPDP with preservation of the splenic vessels (the superior window approach in the Kimura technique). Our gastrohepatic ligament approach for robotic SPDP included four steps. First, the gastrohepatic ligament was divided extensively, and the pancreas was confirmed (step 1). In this step, we did not lift the stomach, nor did we divide the gastrocolic ligament. Next, the superior and inferior borders of the pancreas were dissected, and the tunneling of the pancreas on the superior mesenteric vein was performed (step 2). Following the division of the pancreas (step 3), the pancreatic body and tail were dissected from the medial to the lateral side with preservation of the splenic vessels (step 4). Using this approach, the pancreas can be directly accessed via the gastrohepatic ligament route and dissected without division of the gastrocolic ligament or retraction of the stomach. The present approach for robotic SPDP preserves splenic vessels, facilitating easy access to the pancreas with minimal dissection, and may be optional in selected patients, including those with low body mass index.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9121744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Radical Antegrade Modular Pancreatosplenectomy for Left-Sided Pancreatic Ductal Adenocarcinoma May Reduce the Local Recurrence Rate. 左侧胰腺导管腺癌根治性前向模块化胰腺脾切除术可降低局部复发率
IF 2.7 3区 医学 Q1 Medicine Pub Date : 2022-01-01 Epub Date: 2022-05-09 DOI: 10.1159/000524927
Sho Kiritani, Junichi Kaneko, Junichi Arita, Takeaki Ishizawa, Nobuhisa Akamatsu, Kiyoshi Hasegawa

Introduction: Although several clinical applications have reported the usefulness of the radical antegrade modular pancreatosplenectomy (RAMPS) procedure for left-sided pancreatic ductal adenocarcinoma, few studies have reported the advantages of RAMPS with respect to the local recurrence (LR) rate.

Methods: As of 2018, 68 and 62 patients underwent RAMPS and standard retrograde pancreatosplenectomy (SRPS). The first recurrence and all subsequent recurrence sites observed on images during a follow-up period and/or chemotherapy. The clinical variables are collected retrospectively.

Results: LR only was found in 5 patients in the RAMPS group (5/68, 7.3%) and in 15 patients in the SRPS group (15/62, 24.2%; p = 0.008) as the first recurrence site. Any chemotherapies were not a risk factor for the incidence of LR. The 5-year cumulative LR rate was significantly lower in patients in the RAMPS group compared with those in the SRPS group (23.6% vs. 49.6%; p = 0.019). The 5-year overall survival was 42.2% in the RAMPS group and 33.0% in the SRPS group (p = 0.251).

Conclusion: The RAMPS procedure for left-sided pancreatic ductal adenocarcinoma may reduce the LR, cumulative LR rates.

简介:尽管已有多项临床应用报道了根治性前路模块化胰腺脾切除术(RAMPS)对左侧胰腺导管腺癌的实用性,但很少有研究报道RAMPS在局部复发率(LR)方面的优势:截至2018年,分别有68例和62例患者接受了RAMPS和标准逆行胰腺脾切除术(SRPS)。在随访期间和/或化疗期间,通过图像观察首次复发和所有后续复发部位。回顾性收集临床变量:RAMPS组有5名患者(5/68,7.3%)首次复发部位为LR,SRPS组有15名患者(15/62,24.2%;P = 0.008)首次复发部位为LR。任何化疗都不是LR发生率的风险因素。与SRPS组相比,RAMPS组患者的5年累积LR率明显较低(23.6% vs. 49.6%; p = 0.019)。RAMPS组的5年总生存率为42.2%,SRPS组为33.0%(P = 0.251):结论:RAMPS术治疗左侧胰腺导管腺癌可降低LR和累积LR率。
{"title":"Radical Antegrade Modular Pancreatosplenectomy for Left-Sided Pancreatic Ductal Adenocarcinoma May Reduce the Local Recurrence Rate.","authors":"Sho Kiritani, Junichi Kaneko, Junichi Arita, Takeaki Ishizawa, Nobuhisa Akamatsu, Kiyoshi Hasegawa","doi":"10.1159/000524927","DOIUrl":"10.1159/000524927","url":null,"abstract":"<p><strong>Introduction: </strong>Although several clinical applications have reported the usefulness of the radical antegrade modular pancreatosplenectomy (RAMPS) procedure for left-sided pancreatic ductal adenocarcinoma, few studies have reported the advantages of RAMPS with respect to the local recurrence (LR) rate.</p><p><strong>Methods: </strong>As of 2018, 68 and 62 patients underwent RAMPS and standard retrograde pancreatosplenectomy (SRPS). The first recurrence and all subsequent recurrence sites observed on images during a follow-up period and/or chemotherapy. The clinical variables are collected retrospectively.</p><p><strong>Results: </strong>LR only was found in 5 patients in the RAMPS group (5/68, 7.3%) and in 15 patients in the SRPS group (15/62, 24.2%; p = 0.008) as the first recurrence site. Any chemotherapies were not a risk factor for the incidence of LR. The 5-year cumulative LR rate was significantly lower in patients in the RAMPS group compared with those in the SRPS group (23.6% vs. 49.6%; p = 0.019). The 5-year overall survival was 42.2% in the RAMPS group and 33.0% in the SRPS group (p = 0.251).</p><p><strong>Conclusion: </strong>The RAMPS procedure for left-sided pancreatic ductal adenocarcinoma may reduce the LR, cumulative LR rates.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10563247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Long-Term Follow-Up after Surgery for Chronic Pancreatitis: A Bicentric Retrospective Experience. 慢性胰腺炎术后长期随访:双中心回顾性研究。
IF 2.7 3区 医学 Q1 Medicine Pub Date : 2022-01-01 DOI: 10.1159/000526263
Niccolò Surci, Claudio Bassi, Roberto Salvia, Giovanni Marchegiani, Luca Casetti, Giacomo Deiro, Christina Bergmann, Klaus Walenta, Dietmar Tamandl, Martin Schindl, Klaus Sahora, Jakob Mühlbacher

Introduction: The impact of surgery on nutritional status, pancreatic function, and symptoms of patients affected by chronic pancreatitis (CP) has not been unequivocally determined. This study aimed to evaluate clinical follow-up after surgery for CP in an Italian-Austrian population.

Materials and methods: Patients operated for CP at two high-volume centers between 2000 and 2018 were analyzed. The following parameters were compared between the pre- and postoperative period: nutritional status, endocrine and exocrine pancreatic functions, and chronic pain.

Results: Overall, 186 patients underwent surgery for CP. Among these, 68 (40%) answered a specific follow-up questionnaire. The body mass index showed a significant increase between pre- and postoperative assessments (21.1 vs. 22.5 p = 0.003). Furthermore, a 60% decrease in the prevalence of chronic pain (81 vs. 21%, p < 0.001) was observed. On the contrary, both exocrine and endocrine pancreatic functions pointed toward a worsening after surgery, with consistent higher rates of patients presenting with diabetes mellitus, as well as patients requiring insulin therapy and oral intake of pancreatic enzymes. The analysis of body composition performed on 40 (24%) patients with a complete imaging pack revealed no significant change in the nutritional status after surgery.

Discussion/conclusion: Despite the good results observed in terms of pain relief, the surgical approach led to a consistent worsening of the global pancreatic function. No significant influence of surgery on the nutritional status of patients was detected.

手术对慢性胰腺炎(CP)患者的营养状况、胰腺功能和症状的影响尚未明确确定。本研究旨在评估意大利-奥地利人群CP手术后的临床随访。材料和方法:对2000年至2018年在两个大容量中心进行CP手术的患者进行分析。比较术前和术后的营养状况、胰腺内分泌和外分泌功能、慢性疼痛。结果:总体而言,186例患者接受了CP手术。其中68例(40%)回答了特定的随访问卷。体重指数在术前和术后评估之间显著增加(21.1比22.5 p = 0.003)。此外,观察到慢性疼痛患病率降低了60%(81%对21%,p < 0.001)。相反,胰腺的外分泌和内分泌功能在手术后都有恶化的趋势,出现糖尿病的患者比例一直较高,需要胰岛素治疗和口服胰酶的患者比例也较高。对40例(24%)患者进行完整影像学检查后的身体成分分析显示,手术后营养状况没有显著变化。讨论/结论:尽管在疼痛缓解方面观察到良好的结果,手术入路导致整体胰腺功能的持续恶化。未发现手术对患者营养状况有显著影响。
{"title":"Long-Term Follow-Up after Surgery for Chronic Pancreatitis: A Bicentric Retrospective Experience.","authors":"Niccolò Surci,&nbsp;Claudio Bassi,&nbsp;Roberto Salvia,&nbsp;Giovanni Marchegiani,&nbsp;Luca Casetti,&nbsp;Giacomo Deiro,&nbsp;Christina Bergmann,&nbsp;Klaus Walenta,&nbsp;Dietmar Tamandl,&nbsp;Martin Schindl,&nbsp;Klaus Sahora,&nbsp;Jakob Mühlbacher","doi":"10.1159/000526263","DOIUrl":"https://doi.org/10.1159/000526263","url":null,"abstract":"<p><strong>Introduction: </strong>The impact of surgery on nutritional status, pancreatic function, and symptoms of patients affected by chronic pancreatitis (CP) has not been unequivocally determined. This study aimed to evaluate clinical follow-up after surgery for CP in an Italian-Austrian population.</p><p><strong>Materials and methods: </strong>Patients operated for CP at two high-volume centers between 2000 and 2018 were analyzed. The following parameters were compared between the pre- and postoperative period: nutritional status, endocrine and exocrine pancreatic functions, and chronic pain.</p><p><strong>Results: </strong>Overall, 186 patients underwent surgery for CP. Among these, 68 (40%) answered a specific follow-up questionnaire. The body mass index showed a significant increase between pre- and postoperative assessments (21.1 vs. 22.5 p = 0.003). Furthermore, a 60% decrease in the prevalence of chronic pain (81 vs. 21%, p < 0.001) was observed. On the contrary, both exocrine and endocrine pancreatic functions pointed toward a worsening after surgery, with consistent higher rates of patients presenting with diabetes mellitus, as well as patients requiring insulin therapy and oral intake of pancreatic enzymes. The analysis of body composition performed on 40 (24%) patients with a complete imaging pack revealed no significant change in the nutritional status after surgery.</p><p><strong>Discussion/conclusion: </strong>Despite the good results observed in terms of pain relief, the surgical approach led to a consistent worsening of the global pancreatic function. No significant influence of surgery on the nutritional status of patients was detected.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10744208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention of Incisional Hernia after Open Hepato-Pancreato-Biliary Surgery: A Systematic Review. 肝胰胆开放性手术后切口疝的预防:一项系统综述。
IF 2.7 3区 医学 Q1 Medicine Pub Date : 2022-01-01 Epub Date: 2021-12-07 DOI: 10.1159/000521169
Robert Memba, Olga Morató, Laia Estalella, Mihai C Pavel, Erik Llàcer-Millán, Mar Achalandabaso, Elisabet Julià, Erlinda Padilla, Carles Olona, Donal O'Connor, Rosa Jorba

Introduction: Most hepato-pancreato-biliary (HPB) procedures are still performed through open approach. Incisional hernia (IH) is one of the most common complications after open surgery. To date, published data on IH after HPB surgery are scarce; therefore, the aim of this study was to assess the current evidence regarding incidence, risk factors, and prevention.

Methods: Medline/PubMed (1946-2020), EMBASE (1947-2020), and the Cochrane library (1995-2020) were searched for studies on IH in open HPB surgery. Animal studies, editorials, letters, reviews, comments, short case series and liver transplant, laparoscopic, or robotic procedures were excluded. The protocol was registered with PROSPERO (CRD42020163296).

Results: A total of 5,079 articles were retrieved. Eight studies were finally included for the analysis. The incidence of IH after HPB surgery ranges from 7.7% to 38.8%. The identified risk factors were body mass index, surgical site infection, ascites, Mercedes or reversed T incisions, and previous IH. Prophylactic mesh might be safe and effective.

Conclusions: IH after open HPB surgery is still an important matter. Some of the risk factors are specific for the HPB operations and the incision type should be carefully considered. Randomized controlled trials are required to confirm the role of prophylactic mesh after HPB operations.

大多数肝胰胆(HPB)手术仍然通过开放的方式进行。切口疝(IH)是开放手术后最常见的并发症之一。迄今为止,关于HPB手术后IH的公开数据很少;因此,本研究的目的是评估目前关于发病率、危险因素和预防的证据。方法:检索Medline/PubMed (1946-2020), EMBASE(1947-2020)和Cochrane图书馆(1995-2020),检索开放HPB手术中IH的研究。动物研究、社论、信件、评论、评论、短病例系列和肝移植、腹腔镜或机器人手术被排除在外。该协议已在PROSPERO注册(CRD42020163296)。结果:共检索到5079篇文献。8项研究最终被纳入分析。HPB术后IH的发生率为7.7% ~ 38.8%。确定的危险因素为体重指数、手术部位感染、腹水、梅赛德斯或逆转T形切口以及既往IH。预防性网状物可能是安全有效的。结论:开放HPB手术后的IH仍然是一个重要的问题。一些危险因素是HPB手术所特有的,应仔细考虑切口类型。需要随机对照试验来证实预防性补片在HPB手术后的作用。
{"title":"Prevention of Incisional Hernia after Open Hepato-Pancreato-Biliary Surgery: A Systematic Review.","authors":"Robert Memba,&nbsp;Olga Morató,&nbsp;Laia Estalella,&nbsp;Mihai C Pavel,&nbsp;Erik Llàcer-Millán,&nbsp;Mar Achalandabaso,&nbsp;Elisabet Julià,&nbsp;Erlinda Padilla,&nbsp;Carles Olona,&nbsp;Donal O'Connor,&nbsp;Rosa Jorba","doi":"10.1159/000521169","DOIUrl":"https://doi.org/10.1159/000521169","url":null,"abstract":"<p><strong>Introduction: </strong>Most hepato-pancreato-biliary (HPB) procedures are still performed through open approach. Incisional hernia (IH) is one of the most common complications after open surgery. To date, published data on IH after HPB surgery are scarce; therefore, the aim of this study was to assess the current evidence regarding incidence, risk factors, and prevention.</p><p><strong>Methods: </strong>Medline/PubMed (1946-2020), EMBASE (1947-2020), and the Cochrane library (1995-2020) were searched for studies on IH in open HPB surgery. Animal studies, editorials, letters, reviews, comments, short case series and liver transplant, laparoscopic, or robotic procedures were excluded. The protocol was registered with PROSPERO (CRD42020163296).</p><p><strong>Results: </strong>A total of 5,079 articles were retrieved. Eight studies were finally included for the analysis. The incidence of IH after HPB surgery ranges from 7.7% to 38.8%. The identified risk factors were body mass index, surgical site infection, ascites, Mercedes or reversed T incisions, and previous IH. Prophylactic mesh might be safe and effective.</p><p><strong>Conclusions: </strong>IH after open HPB surgery is still an important matter. Some of the risk factors are specific for the HPB operations and the incision type should be carefully considered. Randomized controlled trials are required to confirm the role of prophylactic mesh after HPB operations.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39789565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Digestive Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1